Stockholders' Equity - Additional Information (Detail)
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
Jul. 01, 2025
USD ($)
$ / shares
shares
|
Jun. 02, 2025
USD ($)
$ / shares
shares
|
Oct. 31, 2025
USD ($)
$ / shares
shares
|
Aug. 31, 2025
$ / shares
shares
|
Feb. 28, 2025
USD ($)
$ / shares
shares
|
Nov. 30, 2022
USD ($)
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2025
€ / shares
|
Jul. 01, 2025
€ / shares
shares
|
Jun. 02, 2025
€ / shares
shares
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Common stock value reduction |
|
|
|
|
|
|
$ 38,100,000
|
|
|
|
|
| Preferred stock, shares issued | shares |
|
|
|
|
|
|
0
|
0
|
|
|
|
| Preferred stock, shares authorized | shares |
|
|
|
|
|
|
37,500,000
|
0
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
|
|
$ 0.01
|
$ 0.01
|
|
|
|
| Preferred stock shares outstanding | shares |
|
|
|
|
|
|
0
|
0
|
|
|
|
| Common stock, shares authorized | shares |
|
|
|
|
|
|
750,000,000
|
750,000,000
|
|
|
|
| Common stock, shares, issued | shares |
|
|
|
|
|
|
363,280,522
|
167,959,752
|
|
|
|
| Share price | € / shares |
|
|
|
|
|
|
|
|
€ 0.1
|
|
|
| Issuance costs |
|
|
|
|
|
|
$ 1,356,000
|
$ 0
|
|
|
|
| Proceeds from issuance of IPO |
|
|
|
|
$ 59,100,000
|
$ 150,000,000
|
|
|
|
|
|
| Proceeds from issuance of pre-funded warrants |
|
|
|
|
|
|
21,503,000
|
0
|
|
|
|
| Issuance costs allocated to pre-funded warrants |
|
|
|
|
|
|
$ 1,357,000
|
0
|
|
|
|
| Proceeds from Issuance Initial Public Offering |
|
|
|
|
$ 59,100,000
|
$ 150,000,000
|
|
|
|
|
|
| Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized | shares |
|
|
|
|
|
|
37,500,000
|
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized | shares |
|
|
|
|
|
|
750,000,000
|
|
|
|
|
| Cash dividends |
|
|
|
|
|
|
$ 0
|
$ 0
|
|
|
|
| Share price | (per share) |
|
|
|
|
$ 2.1
|
|
$ 0.01
|
|
€ 0.1
|
|
|
| Common stock issuance price, cash |
|
|
|
|
|
|
$ 18,300,000
|
|
|
|
|
| Issuance of common shares, net of issuance costs ,Shares | shares |
|
|
|
|
26,190,477
|
|
85,660,979
|
|
|
|
|
| Stock issued during period, convertible share | shares |
|
|
|
|
|
|
6,185,904
|
|
|
|
|
| Common Stock [Member] | Option Exercisable [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Additional common shares public offering price | shares |
|
|
|
|
3,928,571
|
|
|
|
|
|
|
| Additional Common Shares Exercised Option | shares |
|
|
|
|
3,928,571
|
|
|
|
|
|
|
| June 2025 PIPE Financing |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Exercise price, warrants | $ / shares |
|
$ 0.01
|
|
|
|
|
|
|
|
|
|
| Offering costs |
|
|
|
|
|
|
$ 1,800,000
|
|
|
|
|
| Issuance costs allocated to pre-funded warrants |
|
|
|
|
|
|
700,000
|
|
|
|
|
| Common shares allocated amount |
|
|
|
|
|
|
1,100,000
|
|
|
|
|
| June 2025 PIPE Financing | Open Market Sale Agreement |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | € / shares |
|
|
|
|
|
|
|
|
|
|
€ 0.1
|
| June 2025 PIPE Financing | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
$ 1.84
|
|
|
|
|
|
|
|
|
|
| Common stock issuance price, cash |
|
$ 18,400,000
|
|
|
|
|
|
|
|
|
|
| Issuance of common shares, net of issuance costs ,Shares | shares |
|
9,993,341
|
|
|
|
|
|
|
|
|
|
| Percentage of no of share owned by shareholders |
|
4.99%
|
|
|
|
|
|
|
|
|
|
| June 2025 PIPE Financing | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
$ 1.84
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of IPO |
|
$ 11,500,000
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant | shares |
|
6,311,006
|
|
|
|
|
|
|
|
|
6,311,006
|
| Proceeds from issuance of pre-funded warrants |
|
$ 29,900,000
|
|
|
|
|
|
|
|
|
|
| Proceeds from Issuance Initial Public Offering |
|
$ 11,500,000
|
|
|
|
|
|
|
|
|
|
| July 2025 PIPE Financing |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | € / shares |
|
|
|
|
|
|
|
|
|
€ 0.1
|
|
| Exercise price, warrants | $ / shares |
$ 0.01
|
|
|
|
|
|
|
|
|
|
|
| Offering costs |
|
|
|
|
|
|
3,300,000
|
|
|
|
|
| Issuance costs allocated to pre-funded warrants |
|
|
|
|
|
|
700,000
|
|
|
|
|
| Common shares allocated amount |
|
|
|
|
|
|
$ 2,600,000
|
|
|
|
|
| July 2025 PIPE Financing | Open Market Sale Agreement |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Exercise price, warrants | $ / shares |
0.01
|
|
|
|
|
|
|
|
|
|
|
| July 2025 PIPE Financing | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
$ 2.19
|
|
|
|
|
|
|
|
|
|
|
| Common stock issuance price, cash |
$ 40,000,000
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common shares, net of issuance costs ,Shares | shares |
18,264,840
|
|
|
|
|
|
|
|
|
|
|
| Percentage of no of share owned by shareholders |
|
4.99%
|
|
|
|
|
|
|
|
|
|
| July 2025 PIPE Financing | Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
$ 2.19
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuance of IPO |
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
| Purchase of warrant | shares |
4,566,210
|
|
|
|
|
|
|
|
|
4,566,210
|
|
| Proceeds from issuance of pre-funded warrants |
$ 50,000,000
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from Issuance Initial Public Offering |
$ 10,000,000
|
|
|
|
|
|
|
|
|
|
|
| October 2025 Public Offering |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Common stock issuance price, cash |
|
|
$ 139,100,000
|
|
|
|
|
|
|
|
|
| Underwriting discounts and commissions |
|
|
Under the terms of the October Underwriting Agreement, the Company granted to the underwriters an option exercisable for 30 days to purchase up to an additional 3,558,750 common stock at the public offering price, less underwriting discounts and commissions. Pursuant to the October Underwriting Agreement, the underwriters exercised the option to purchase the full amount of the additional 3,558,750 common stock.
|
|
|
|
|
|
|
|
|
| October 2025 Public Offering | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
$ 5.48
|
|
|
|
|
|
|
|
|
| Issuance of common shares, net of issuance costs ,Shares | shares |
|
|
23,725,000
|
|
|
|
|
|
|
|
|
| Apeiron [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share price | $ / shares |
|
|
|
$ 2.19
|
$ 2.1
|
|
|
|
|
|
|
| Issuance of common shares, net of issuance costs ,Shares | shares |
|
|
|
8,675,799
|
10,835,718
|
|
|
|
|
|
|